You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
以嶺藥業(002603.SZ):子公司獲婦血安片藥品補充申請批件併成為藥品上市許可持有人
格隆匯 04-20 18:31

格隆匯4月20日丨以嶺藥業(002603.SZ)公佈,全資子公司衡水以嶺藥業有限公司收到國家藥品監督管理局核准簽發的《藥品補充申請批准通知書》,藥品通用名稱婦血安片。

婦血安片是2001年國家藥品監督局批准的婦科中藥新藥,其功能主治為:活血化瘀,止血調經。用於血瘀所致月經過多及經期延長。

婦血安片獲得《藥品補充申請批准通知書》,標誌着該產品已完成藥品上市許可持有人變更工作,公司全資子公司衡水以嶺藥業有限公司已成為該藥品上市許可持有人,進一步豐富了公司產品管線,有利於公司的可持續發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account